The Effect of Stingless Bee Honey Mouthrinse on Dental Plaque Accumulation

NCT ID: NCT06223243

Last Updated: 2024-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2024-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mouthrinses are recommended as a complement to mechanical methods in oral hygiene procedures to prevent and control periodontal diseases. Chlorhexidine mouthrinse has been used as a chemical plaque control agent for many years. However, in spite of its potent antimicrobial and antiplaque properties, there have been various reports of the undesirable adverse effects of chlorhexidine mouthrinse. This creates the need to look for an alternative mouthrinse that can also help in controlling plaque.

Stingless bee honey is an alternative agent which is increasingly known for its better properties and easily available compared to other types of honey. It has been reported to have many benefits for the oral cavity such as antibacterial, anti-inflammatory, and healing properties which makes it a potential therapeutic agent in periodontal therapy. However, there is a lack of clinical studies showing its efficacy in plaque control as a mouthrinse.

Hence, this study aims to investigate the ability of stingless bee honey mouthrinse to reduce plaque accumulation. This will be done through a randomised clinical trial whereby subjects will be prescribed with a mouthrinse formulation and instructed to refrain from any tooth cleaning procedure. The patient's plaque score will be recorded before and after the intervention to measure the effectiveness of the mouthrinse.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objectives:

i. To investigate the patients' plaque level after use of stingless bee honey mouthrinse in a clinical trial. ii. To investigate patients' acceptance to stingless bee honey mouthrinse. iii. To compare plaque level after use of stingless bee honey mouthrinse to chlorhexidine mouthrinse.

This is a randomised, double-blinded, placebo-controlled clinical study that will be conducted at the Faculty of Dentistry, Universiti Sains Islam Malaysia (USIM). Application of ethical approval will be made to USIM's medical ethical committee of the Faculty of Medicine and Health Science.

Patients who seek scaling and polishing treatment at Faculty of Dentistry, USIM were invited to participate in study. Written and informed consent were obtained from the participants. As this is a pilot study, sample size calculation was not performed. A total of ten participants per group were recruited for the study.

Pre-intervention, plaque score and BPE were taken at baseline by a single clinician (NAH), a periodontist. This was to reduce any variation in plaque score recording between different clinicians. Both the patients and the clinician were blinded to the intervention given to reduce bias. After recording the plaque score, scaling and prophylaxis were performed by periodontists (NAH, NHMB \& MAS). This was to ensure that all participants start at an equal oral hygiene level and that the score taken after three days will be purely from plaque formation and not from the negligence of oral hygiene.

Three different mouthrinse formulations were prepared for this study: (1) stingless bee honey-based mouthrinse (Bayu kelulut ®) containing honey diluted with distilled water to a concentration of 1:1, (2) 0.12% chlorhexidine (Oradex Antibacterial Mouthwash, Malaysia. Reg no: MAL06011901XCZ), and (3) placebo (negative control) containing saline solution. The Malaysian stingless bee honey, Bayu Kelulut ® is a product certified by Malaysian Good Manufacturing Practices and Malaysian Agricultural Research and Development Institute (MARDI), and chlorhexidine is registered under the National Pharmaceutical Regulatory Agency, Ministry of Health. These mouthrinse preparations were packed, sealed and coded in identical bottles before starting the study.

60ml of mouthrinse in a sealed bottle were prescribed by two dental students at random. These formulations were mixed in Laboratory level 18, Faculty of Dentistry, Universiti Sains Islam Malaysia and kept in the refrigerator between 2-8°C. Patients were instructed to refrain from all forms of tooth cleaning and rinse 10ml of mouthrinse twice daily for two minutes. This was done in three days.

After three days, the same clinician (NAH) measured the plaque score and BPE again. Prophylaxis were given.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Plaque Accumulation Patient Acceptance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomised clinical trial, blinded and performed in 3 parallel groups.
Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Tthe assessor was not involved in the mouthrinse assignment. Besides, the bottles were covered to prevent from showing the color of mouthrinse.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

stingless bee honey

stingless bee honey mouthrinse was prescribed to participants assigned to this group.

Group Type EXPERIMENTAL

Stingless bee honey mouthrinse

Intervention Type OTHER

Three bottles of 90ml of stingless bee honey of 20% concentration was given to each subject. This mouthrinse preparation was instructed for subjects to be taken 30ml each, thrice daily for three days.

chlorhexidine

chlorhexidine mouthrinse was prescribed to participants assigned to this group.

Group Type ACTIVE_COMPARATOR

chlorhexidine mouthrinse

Intervention Type OTHER

Subjects were instructed to rinse with 30ml of chlorhexidine mouthrinse thrice daily for three days.

normal saline

Normal saline mouthrinse was prescribed to participants assigned to this group.

Group Type PLACEBO_COMPARATOR

normal saline mouthrinse

Intervention Type OTHER

Subjects were instructed to rinse with 30ml of normal saline (0.9% concentration) thrice daily for three days.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stingless bee honey mouthrinse

Three bottles of 90ml of stingless bee honey of 20% concentration was given to each subject. This mouthrinse preparation was instructed for subjects to be taken 30ml each, thrice daily for three days.

Intervention Type OTHER

normal saline mouthrinse

Subjects were instructed to rinse with 30ml of normal saline (0.9% concentration) thrice daily for three days.

Intervention Type OTHER

chlorhexidine mouthrinse

Subjects were instructed to rinse with 30ml of chlorhexidine mouthrinse thrice daily for three days.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Medically healthy participants aged between 18-40
2. Healthy gingiva or localised gingivitis with the highest Basic Periodontal Examination (BPE) score of 2
3. Presence of at least 20 natural teeth

Exclusion Criteria

1. Diabetes
2. Physical and/or mental disabilities that may interfere with receiving mouthrinse instructions
3. Orthodontic or prosthodontic appliances
4. Undergoing antibiotic/antimicrobial therapy
5. Current smoker
6. Abnormal saliva secretion rate
7. Pregnancy
8. Allergy to honey or bee stings
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universiti Sains Islam Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

NUR AYMAN ABDUL HAYEI

Clinical Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

NUR AYMAN ABDUL HAYEI

Role: PRINCIPAL_INVESTIGATOR

FACULTY OF DENTISTRY, UNIVERSITI SAINS ISLAM MALAYSIA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Students Dental Clinic, Faculty of Dentistry, University Sains Islam Malaysia.

Kuala Lumpur, Pandan Indah, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SBH Mouthrinse

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.